In this episode, we are joined by Joel White, President of Horizon Government Affairs, who will discuss the Inflation Reduction Act, PBM reform, drug shortages, Medicare physician payment and telehealth issues.

If you have questions for our guests or suggestions for future topics, send us an email at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions only and not endorsed by Cencora or affiliates. Neither OnCall nor Cencora control the accuracy of third party information. Accessing those sites is at your own risk and subject of their terms of use.

In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective.

If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].

In this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of Head of State Government Advocacy discuss legislation surrounding biosimilars.

Our next episode will feature information on the biosimilar payer perspective. If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].

In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in the market.

Our next episode will feature information on biosimilar legislation. If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].

In this episode, the first of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss Biosimilars 101 and resources to utilize to stay better informed.

Our next episode will feature information on the current Biosimilar landscape and what we can expect to see in the market. If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected]. 

In this episode, the eleventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses drug pricing and shortages.

If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].

In this episode, the tenth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses transparency in the House, competition, and lower costs on drugs and services.

Our next episode will feature information on drug pricing and shortages. If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].

In this episode, the ninth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses health issues around Medicare physician payment, and PBM reform.

Our next episode will feature information on transparency in the House, competition, and lower costs on drugs and services. If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].

In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug Price Negotiations, PBM reform, and elections.

That's all for this episode of OnCall. Our next episode will feature information on politics and policy, and physician payment issues. If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].

In this episode, the seventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses Congress and the fiscal backdrop.

Our next episode will feature information on issues regarding MPFS, Medicare Drug Price Negotiations, PBM reform, and elections. If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].